What would be the daily dose of Lantus (insulin glargine) for an adult patient with type 2 diabetes currently taking 160 units of 70/30 (NPH/regular) insulin daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Converting from 70/30 Insulin to Lantus: Dosing Strategy

When switching from 160 units daily of 70/30 insulin to Lantus, start with approximately 90 units once daily (roughly 55-60% of the total 70/30 dose), as the 70/30 formulation contains 30% rapid-acting insulin that will be eliminated in the conversion. 1, 2

Rationale for Dose Calculation

  • The 70/30 insulin formulation contains 70% basal (NPH) and 30% rapid-acting components, meaning only the basal portion should be converted to Lantus 1, 2
  • When converting from premixed insulin to basal-only insulin, the American Diabetes Association recommends using approximately 80% of the total daily dose as a starting point for basal insulin 2
  • For 160 units of 70/30 daily, this translates to approximately 128 units using the 80% rule, but a more conservative approach of 90-100 units (55-60% of total dose) is safer initially given the elimination of the prandial component 2

Critical Considerations When Switching

Eliminating the 30% rapid-acting component (approximately 48 units daily) means you will lose postprandial glucose coverage, requiring close monitoring and likely addition of mealtime insulin or a GLP-1 receptor agonist if HbA1c remains above target. 2

  • The risk of nocturnal hypoglycemia should decrease with Lantus compared to 70/30 insulin, but if hypoglycemia occurs during titration, reduce the dose by 10-20% immediately 2
  • Continue metformin throughout the transition unless contraindicated, as this combination provides superior glycemic control with reduced insulin requirements 3, 1
  • Discontinue sulfonylureas when transitioning to prevent additive hypoglycemia risk 1

Titration Strategy

Increase Lantus by 2-4 units every 3 days based on fasting glucose readings until reaching target of 80-130 mg/dL, rather than waiting for severe hyperglycemia. 3, 2

  • If fasting glucose is 140-179 mg/dL, increase by 2 units every 3 days 3
  • If fasting glucose is ≥180 mg/dL, increase by 4 units every 3 days 3
  • Daily fasting blood glucose monitoring is essential during titration 3

When to Add Prandial Coverage

When Lantus dose exceeds 0.5 units/kg/day (approximately 90-100 units for most adults) and postprandial glucose remains elevated, add rapid-acting insulin before the largest meal starting at 4 units, or consider a GLP-1 receptor agonist for postprandial control with weight loss benefits. 3, 2

  • Start prandial insulin with 4 units of rapid-acting insulin before the largest meal, or use 10% of the current basal dose 3
  • GLP-1 receptor agonists provide comparable HbA1c reduction with lower hypoglycemia risk and weight loss rather than weight gain 2

Common Pitfalls to Avoid

  • Starting too conservatively when switching from premixed insulin leads to prolonged hyperglycemia and delayed achievement of glycemic targets 2
  • Do not continue escalating Lantus beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia, as this causes overbasalization with increased hypoglycemia risk 3
  • Monitor for signs of overbasalization: bedtime-to-morning glucose differential ≥50 mg/dL, hypoglycemia, and high glucose variability 3

References

Guideline

Insulin 70/30 Therapy for Type 2 Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Switching from 70/30 Insulin to Toujeo: Dosing Strategy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Is it safe to take 20 units of Novolog Mix 70/30 (insulin aspart protamine/insulin aspart) twice a day?
Can Novolin 70/30 (insulin aspart and insulin human) be taken twice daily?
What is the recommended increase in NPH (Neutral Protamine Hagedorn) insulin dose for a patient with hyperglycemia, currently taking 70 units of NPH insulin and requiring an additional 23 units of Novolog (insulin aspart), with blood glucose readings of 303 and 310?
What should be the starting dose of Lantus (insulin glargine) and the insulin-to-carbohydrate ratio (ICR) and insulin sensitivity factor (ISF) for a male patient with a hemoglobin A1C (HbA1C) level of 11.9%, who weighs 71.4 kg and has a body mass index (BMI) of 23, and has previously been on insulin therapy?
How do I switch from NPH (Neutral Protamine Hagedorn) Humulin N (insulin isophane) to 70/30 insulin?
Can ethanol (EtOH) exacerbate tremors in patients with parkinsonism, particularly those with a history of alcohol use?
What are the next steps for a patient taking 200mg of Zoloft (sertraline) who reports feeling like a zombie at times?
What alternative antianxiety medication can be recommended for a patient with a history of failing Prozac (fluoxetine) and experiencing increased episodic anxiety throughout the day?
Is Prolia (denosumab) medically necessary for a patient with age-related osteoporosis, severe lower back pain, and a history of treatment with Alendronate (alendronic acid), who has been on Prolia for over 24 months and has shown improved bone mineral density, but has incomplete recent DEXA scan results?
Can uveitis be a complication in patients with Löfgren syndrome?
Can hydrocortisone (corticosteroid), antifungal (anti-fungal medication), and zinc oxide be mixed together for topical application?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.